Movement Alert｜Spyre Therapeutics Rises 11.41% in Regular Trading, Trading at $104.42

Market Focus07-15

On July 15, Spyre Therapeutics rose 11.41% in regular trading, trading at $104.42 USD/share, with Turnover of $74.60 million.

Within the Biotechnology sector where Spyre Therapeutics belongs, individual stock performance was mixed. Among individual stocks, Nextcure Inc. up 226.15%, Biogen down 8.48%, AbbVie down 1.26%, Shuttle Pharmaceuticals Inc up 30.07%, Gilead Sciences down 0.54%.

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease therapeutics through long-acting antibodies and antibody combinations targeting α4β7, TL1A, and IL-23. The company reported Q4 net loss of $0.70 per share and holds $757 million in cash with runway into Q2 2028.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116922694?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 00:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116922694","market":"us","top_or_hot":-1,"title":"Movement Alert｜Spyre Therapeutics Rises 11.41% in Regular Trading, Trading at $104.42","media":"Market Focus","content":"<p><p>On July 15, Spyre Therapeutics rose 11.41% in regular trading, trading at $104.42 USD/share, with Turnover of $74.60 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, individual stock performance was mixed. Among individual stocks, Nextcure Inc. up 226.15%, Biogen down 8.48%, AbbVie down 1.26%, Shuttle Pharmaceuticals Inc up 30.07%, Gilead Sciences down 0.54%.</p><p>Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease therapeutics through long-acting antibodies and antibody combinations targeting α4β7, TL1A, and IL-23. The company reported Q4 net loss of $0.70 per share and holds $757 million in cash with runway into Q2 2028.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Spyre Therapeutics Rises 11.41% in Regular Trading, Trading at $104.42</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Spyre Therapeutics Rises 11.41% in Regular Trading, Trading at $104.42\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-15 00:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 15, Spyre Therapeutics rose 11.41% in regular trading, trading at $104.42 USD/share, with Turnover of $74.60 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, individual stock performance was mixed. Among individual stocks, Nextcure Inc. up 226.15%, Biogen down 8.48%, AbbVie down 1.26%, Shuttle Pharmaceuticals Inc up 30.07%, Gilead Sciences down 0.54%.</p><p>Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease therapeutics through long-acting antibodies and antibody combinations targeting α4β7, TL1A, and IL-23. The company reported Q4 net loss of $0.70 per share and holds $757 million in cash with runway into Q2 2028.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRE","symbol_name":"SPYRE THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1116922694","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116922694","pubTimestamp":1784044976,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 15, Spyre Therapeutics rose 11.41% in regular trading, trading at $104.42 USD/share, with Turnover of $74.60 million.Within the Biotechnology sector where Spyre Therapeutics belongs,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYRE":"SPYRE THERAPEUTICS INC"},"translate_title":"走势警报|Spyre Therapeutics 常规交易上涨 11.41%，交易价格为 104.42 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRE":1},"content_text":"On July 15, Spyre Therapeutics rose 11.41% in regular trading, trading at $104.42 USD/share, with Turnover of $74.60 million.Within the Biotechnology sector where Spyre Therapeutics belongs, individual stock performance was mixed. Among individual stocks, Nextcure Inc. up 226.15%, Biogen down 8.48%, AbbVie down 1.26%, Shuttle Pharmaceuticals Inc up 30.07%, Gilead Sciences down 0.54%.Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease therapeutics through long-acting antibodies and antibody combinations targeting α4β7, TL1A, and IL-23. The company reported Q4 net loss of $0.70 per share and holds $757 million in cash with runway into Q2 2028.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116922694","isCrawlerRequest":true}